Rombos Yannis, Tzanetea Revekka, Kalotychou Vassiliki, Konstantopoulos Kostas, Simitzis Spyros, Tassiopoulos Thomas, Aessopos Athanasios, Fessas Phaedon
1st Department of Internal Medicine, University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece.
Blood Cells Mol Dis. 2002 Mar-Apr;28(2):283-7. doi: 10.1006/bcmd.2002.0489.
Sickle cell disease patients who acquire iron deficiency may experience a degree of amelioration from painful crises in terms of frequency, severity, and duration. This observation prompted us to identify the potential utility of iron load reduction in the management of this disease. Thirteen sickle cell patients not ameliorated by conventional treatment entered a weekly venesection protocol. Hematological values and painful crises of all degrees of severity were recorded and compared to those of the last 12 months before venesection for each case separately ("historical controls"). A decrease was noted in the frequency and intensity of several types of painful crises. Reduction of iron load by venesection seems to be a simple, safe, side-effect-free, and efficient way of preventing and ameliorating to a large extent painful crises in sickle cell disease. The biological effects of venesection on other parameters of sickle cell disease remain to be determined.
患有缺铁性贫血的镰状细胞病患者在疼痛危机的频率、严重程度和持续时间方面可能会有一定程度的缓解。这一观察结果促使我们确定降低铁负荷在该疾病管理中的潜在效用。13名常规治疗无改善的镰状细胞病患者进入每周放血方案。记录所有严重程度的血液学值和疼痛危机,并分别与每个病例放血前的最后12个月(“历史对照”)进行比较。注意到几种类型疼痛危机的频率和强度有所降低。通过放血降低铁负荷似乎是一种简单、安全、无副作用且有效的方法,可在很大程度上预防和缓解镰状细胞病的疼痛危机。放血对镰状细胞病其他参数的生物学影响仍有待确定。